diazooxonorleucine has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, R; Alt, J; Elgogary, A; Englert, J; Ferraris, D; Jančařík, A; Le, A; Majer, P; Monincová, L; Nedelcovych, M; Pate, K; Powell, J; Rais, R; Rojas, C; Slusher, BS; Tan, J; Tenora, L | 1 |
| Hirose, Y; Ohba, S | 1 |
| Arismendi-Morillo, G; Augur, ZM; Bronson, RT; Chinopoulos, C; Domin, MA; Greenwood, B; Hill, C; Kiebish, MA; Kondakci, G; Li, M; Mukherjee, P; Narain, NR; Seyfried, TN | 1 |
3 other study(ies) available for diazooxonorleucine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
Topics: Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Diazooxonorleucine; Female; Glioblastoma; Glutamine; Haplorhini; Humans; Mice; Mice, Nude; Prodrugs | 2016 |
L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
Topics: Antineoplastic Agents; Asparaginase; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diazooxonorleucine; Glioblastoma; Humans | 2020 |
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
Topics: Animals; Body Weight; Brain; Brain Neoplasms; Caloric Restriction; Cell Line, Tumor; Cell Proliferation; Diazooxonorleucine; Diet, Ketogenic; Disease Models, Animal; Female; Fermentation; Glioblastoma; Glucose; Glutamine; Humans; Immunohistochemistry; Ketone Bodies; Ketones; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation | 2019 |